Literature DB >> 26564230

DNA damage response in cisplatin-induced nephrotoxicity.

Shiyao Zhu1, Navjotsingh Pabla2, Chengyuan Tang1, Liyu He1, Zheng Dong3,4.   

Abstract

Cisplatin and its derivatives are widely used chemotherapeutic drugs for cancer treatment. However, they have debilitating side effects in normal tissues and induce ototoxicity, neurotoxicity, and nephrotoxicity. In kidneys, cisplatin preferentially accumulates in renal tubular cells causing tubular cell injury and death, resulting in acute kidney injury (AKI). Recent studies have suggested that DNA damage and the associated DNA damage response (DDR) are an important pathogenic mechanism of AKI following cisplatin treatment. Activation of DDR may lead to cell cycle arrest and DNA repair for cell survival or, in the presence of severe injury, kidney cell death. Modulation of DDR may provide novel renoprotective strategies for cancer patients undergoing cisplatin chemotherapy.

Entities:  

Keywords:  Apoptosis; Cisplatin; DNA damage; Kidney; Nephrotoxicity; P53

Mesh:

Substances:

Year:  2015        PMID: 26564230      PMCID: PMC4734632          DOI: 10.1007/s00204-015-1633-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  86 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Sibling rivalry in checkpoint control of cell cycle and DNA damage response.

Authors:  Navjotsingh Pabla; Zheng Dong
Journal:  Cell Cycle       Date:  2012-05-15       Impact factor: 4.534

3.  Platinum-induced kidney damage: Unraveling the DNA damage response (DDR) of renal tubular epithelial and glomerular endothelial cells following platinum injury.

Authors:  Katharina Krüger; Jürgen Thomale; Nikolina Stojanović; Maja Osmak; Christian Henninger; Stefanie Bormann; Gerhard Fritz
Journal:  Biochim Biophys Acta       Date:  2015-01-04

4.  The DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) Are stimulated by bulky adduct-containing DNA.

Authors:  Michael G Kemp; Laura A Lindsey-Boltz; Aziz Sancar
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

Review 5.  Cell cycle control in the kidney.

Authors:  Dana Thomasova; Hans-Joachim Anders
Journal:  Nephrol Dial Transplant       Date:  2014-12-23       Impact factor: 5.992

6.  Involvement of p53-transactivated Puma in cisplatin-induced renal tubular cell death.

Authors:  Kazuhiko Tsuruya; Hideki Yotsueda; Hirofumi Ikeda; Masatomo Taniguchi; Kohsuke Masutani; Hideko Hayashida; Hideki Hirakata; Mitsuo Iida
Journal:  Life Sci       Date:  2008-08-12       Impact factor: 5.037

Review 7.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

8.  Protection of renal cells from cisplatin toxicity by cell cycle inhibitors.

Authors:  Peter M Price; Robert L Safirstein; Judit Megyesi
Journal:  Am J Physiol Renal Physiol       Date:  2003-09-09

Review 9.  Checkpoint kinase 1 in DNA damage response and cell cycle regulation.

Authors:  Mallikarjun Patil; Navjotsingh Pabla; Zheng Dong
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

10.  c-Jun regulates the stability and activity of the p53 homologue, p73.

Authors:  Wen Hong Toh; M M Siddique; Lakshmanane Boominathan; Kai Wei Lin; Kanaga Sabapathy
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

View more
  55 in total

1.  Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma.

Authors:  Yasuhiro Arakawa; Yoshihiro Shirai; Kazumi Hayashi; Yujiro Tanaka; Akira Matsumoto; Katsunori Nishikawa; Shingo Yano
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

2.  Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction.

Authors:  Abdel-Gawad S Shalkami; Mohamed I A Hassan; Ahmed A Abd El-Ghany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-31       Impact factor: 3.000

3.  Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine.

Authors:  J E McDuffie; Y Chen; J Y Ma; S Lee; K M Lynch; D M Hamlin; L Nguyen; M Rizzolio; M Sonee; S Snook
Journal:  Toxicol Res (Camb)       Date:  2016-06-07       Impact factor: 3.524

Review 4.  DNA damage response in nephrotoxic and ischemic kidney injury.

Authors:  Mingjuan Yan; Chengyuan Tang; Zhengwei Ma; Shuang Huang; Zheng Dong
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-27       Impact factor: 4.219

Review 5.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

6.  53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells.

Authors:  Shuhui Hong; Xiaoyan Li; Ying Zhao; Qifeng Yang; Beihua Kong
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

7.  Stress granules are formed in renal proximal tubular cells during metabolic stress and ischemic injury for cell survival.

Authors:  Shixuan Wang; Sang-Ho Kwon; Yunchao Su; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

8.  Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.

Authors:  Si Luo; Zhen Pan; Shuang Liu; Shujing Yuan; Nianlong Yan
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

9.  Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.

Authors:  Liping Sun; Jing Liu; Yanggang Yuan; Xinzhou Zhang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-16

10.  Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity.

Authors:  Tugce Boran; Aysenur Gunaydin; Ayse Tarbin Jannuzzi; Eren Ozcagli; Buket Alpertunga
Journal:  Toxicol Res (Camb)       Date:  2019-07-31       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.